< Back to companies
BioCODE

BioCODE

Stellenbosch, South Africa

BioCODE is a South African medical technology startup spun out of Stellenbosch University, specializing in inflammation-centered diagnostic solutions. Their flagship product, Biolab Microclots, utilizes patented microclot detection technology involving fluorescent microscopy and flow cytometry to diagnose conditions such as Long COVID, cardiovascular diseases, and chronic inflammation. By developing point-of-care smart sensing solutions, BioCODE empowers healthcare professionals with advanced diagnostic tools capable of identifying blood anomalies missed by conventional tests. This approach shifts the clinical focus towards early prevention and management of chronic and post-viral syndromes, transforming healthcare delivery through accessible and accurate medical technologies.

Share
Shareable draft
Get Involved in BioCODE

Company Info

Founded
2019
Website
www.biocode.co.za/

Categories

PreventionPoint-of-Care DevicesDiagnostics

Disease Areas

Technologies

Point-of-Care DevicesBiosensorsSensor TechnologyBiomarkers
Only accessible to MedStartr community members. Join now

What do you think of BioCODE?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in BioCODE
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free